The Rise Fund logo

The Rise Fund

North America, California, United States, San Francisco

Description

The Rise Fund is a leading global impact investing fund managed by TPG, a prominent private equity firm. Launched in 2016, the fund is dedicated to achieving measurable social and environmental impact alongside competitive financial returns. It operates on the belief that large-scale global problems can be solved with market-based solutions, and it employs a proprietary 'Impact Multiple of Money' (IMM) methodology to quantify and manage the impact generated by its portfolio companies.

The fund's investment strategy focuses on growth-stage companies across seven core sectors: Education, Energy, Food & Agriculture, Financial Services, Healthcare, Technology, Media & Telecom (TMT), and Real Estate. The Rise Fund seeks out businesses that are already established and demonstrate a proven ability to generate positive impact, providing them with capital and strategic support to scale their operations and amplify their societal contributions. This approach emphasizes deep engagement with portfolio companies to drive both financial performance and impact outcomes.

The Rise Fund has successfully raised significant capital, underscoring its prominence in the impact investing landscape. The Rise Fund I closed with over $2 billion in commitments in 2017, demonstrating strong investor confidence in its dual mandate. Building on this success, The Rise Fund II closed in 2021 with $2.6 billion, further expanding its capacity to invest in impactful enterprises globally. Typically, the fund targets equity investments ranging from $50 million to $250 million per company, reflecting its focus on substantial growth equity rounds.

Investor Profile

The Rise Fund has backed more than 64 startups, with 2 new investments in the last 12 months alone. The firm has led 41 rounds, about 64% of its total and boasts 8 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, India, Canada.
  • Strong thematic focus on Health Care, Biotechnology, Financial Services.
  • Led 2 rounds in the past year.
  • Typical check size: $50M – $250M.

Stage Focus

  • Series C (19%)
  • Series B (19%)
  • Series Unknown (17%)
  • Series A (13%)
  • Series D (11%)
  • Private Equity (8%)
  • Series E (5%)
  • Seed (5%)
  • Series F (3%)
  • Post Ipo Equity (2%)

Country Focus

  • United States (67%)
  • India (9%)
  • Canada (3%)
  • Israel (3%)
  • Argentina (3%)
  • China (3%)
  • Kenya (2%)
  • Hong Kong (2%)
  • United Kingdom (2%)
  • Botswana (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Financial Services
  • Therapeutics
  • Software
  • Medical
  • Fintech
  • Solar
  • Education
  • Renewable Energy
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Rise Fund frequently co-invest with?

Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 4
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
KCK
North America, New York, United States, New York
Co-Investments: 3
TR
North America, California, United States, San Francisco
Co-Investments: 3
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 8
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
TPG
North America, California, United States, San Francisco
Co-Investments: 3
Warburg Pincus
Europe, Madrid, Spain, Boadilla Del Monte
Co-Investments: 3
TPG Growth
North America, California, United States, San Francisco
Co-Investments: 6
Venrock
North America, California, United States, Palo Alto
Co-Investments: 4

Which angels does The Rise Fund often collaborate with?

SB
North America, California, United States
Shared Deals: 1
PH
Europe, England, United Kingdom, London
Shared Deals: 1
AL
North America, California, United States, Palo Alto
Shared Deals: 1
JS
North America, California, United States, Palo Alto
Shared Deals: 1
ES
North America, California, United States, Mountain View
Shared Deals: 1
EW
North America, California, United States, San Francisco
Shared Deals: 1
RH
North America, California, United States
Shared Deals: 1
SS
North America, Florida, United States, Miami
Shared Deals: 1
JB
North America, Washington, United States, Seattle
Shared Deals: 1
SJ
North America, California, United States
Shared Deals: 1

What are some of recent deals done by The Rise Fund?

Eruditus Executive Education

Mumbai, Maharashtra, India

Eruditus provides global access to executive education programs, boot camps, and senior executive trainings.

Continuing EducationEdTechEducationSkill Assessment
Series FOct 18, 2024
Amount Raised: $150,000,000
BillEase

Makati, Manila, Philippines

BillEase is a consumer finance app with AI-driven financial products and services.

FinanceFinancial ServicesFinTechPaymentsSoftware
Series CSep 3, 2024
Hayden AI

San Francisco, California, United States

Hayden AI is an AI platform offering geospatial analytics, transit management, and technology services.

AnalyticsArtificial Intelligence (AI)Big DataComputer VisionGeospatialGovTechMachine Learning
Series CJul 10, 2024
Amount Raised: $90,000,000
Foodsmart

San Francisco, California, United States

Foodsmart provides a digital nutrition platform that uses personalized dietary recommendations to improve health outcomes.

FitnessFood and BeverageNutritionWellness
Private EquityJun 26, 2024
Amount Raised: $200,000,000
Sionna Therapeutics

Natick, Massachusetts, United States

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
Series CMar 6, 2024
Amount Raised: $182,000,000
Bicara Therapeutics

Cambridge, Massachusetts, United States

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics
Series CDec 12, 2023
Amount Raised: $165,000,000
RefleXion Medical

Hayward, California, United States

RefleXion Medical is a developer of biologically-guided radiotherapy systems for patients with cancer.

BiotechnologyHealth CareMedicalMedical DeviceTherapeutics
Series UnknownNov 15, 2023
Amount Raised: $105,000,000
UBQ Materials

Tel Aviv, Tel Aviv, Israel

UBQ Materials converts unsorted household waste into a climate-positive thermoplastic material.

Advanced MaterialsCleanTechGreenTechManufacturing
Series UnknownSep 13, 2023
Amount Raised: $70,000,000
Banyan Treatment Center

Pompano Beach, Florida, United States

Banyan Treatment Center provide addiction treatment programs and detox for a variety of substances.

Addiction TreatmentHealth CareHospital
Series UnknownJun 2, 2023
Form Energy

Somerville, Massachusetts, United States

Form Energy develops and commercializes a low-cost battery system that can store wind and solar energy for a long duration.

BatteryEnergyEnergy StorageEnvironmental EngineeringRenewable Energy
Series EOct 4, 2022
Amount Raised: $450,000,000